Nearing its 50th year, AHFS Drug Information for 2008 once again will be updated by over 60% to include thousands of point-by-point revisions and critical updates to help you provide the most accurate recommendations for your patients’ drug therapy.

AHFS references are evidence-based and peer-reviewed, compiled without the influence of manufacturers, insurers, regulators, or other interested parties. No other drug information sources can make this claim.

AHFS DI is the only printed drug reference that has been designated as an official compendium by the US Congress.

AHFS DI contains information from medical literature and expert advice from over 500 medical scientists, physicians, pharmacists, pharmacologists, and other professionally qualified individuals that goes beyond FDA-approved labeling.

Featuring:

• Expanded and revised content for 2008, including many new monographs
• Extensive off-label usages
• Expert advice and peer reviewed by over 500 medical scientists, physicians, pharmacists, pharmacologists, and other professionally qualified individuals
• Over 40,000 represented medicines and over 100,000 drug products
• Over 70,000 uniquely cited references
• Only well-established, referenced laboratory test interferences
• Comparative pricing for most Rx and OTC monographs

Monographs include: drug interactions; adverse reactions; cautions and toxicity; therapeutic perspective; specific dosage and administration information; preparations, chemistry, and stability; pharmacology and pharmacokinetics; contraindications; and more.

This title updates: Monthly

Gerald K. McEvoy, Pharm.D.
Editor

Elaine K. Snow, B.S. Pharm.
Senior Associate Editor